For example, chemokines and their receptors can promote AD pathology by inducing the production of Aβ (such as CXCR2 and CCR3), and also reduce the deposition of Aβ (such as CX3CR1, CXCR3, and CCR2), respectively. Here, CX3CR1 is linked to Alzheimer disease.